Metropolitan Life Insurance Company (MetLife)’s Adtran ADTN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,056	Closed	-$16.6K	–	52
2024 Q1	$16.6K	Sell	3,056 -1,183	-28%	-$7.54K	﹤0.01%	1945
2023 Q4	$31.1K	Hold	4,239	–	–	﹤0.01%	1700
2023 Q3	$34.9K	Hold	4,239	–	–	﹤0.01%	1595
2023 Q2	$44.6K	Buy	4,239 +370	+10%	+$3.67K	﹤0.01%	1493
2023 Q1	$61.4K	Sell	3,869 -879	-19%	-$15.3K	﹤0.01%	1279
2022 Q4	$89.2K	Buy	4,748 +401	+9%	+$8.05K	﹤0.01%	1118
2022 Q3	$85.1K	Buy	4,347 +1,297	+43%	+$28.3K	﹤0.01%	1111
2022 Q2	$53.5K	Hold	3,050	–	–	﹤0.01%	1465
2022 Q1	$56.3K	Sell	3,050 -8,865	-74%	-$176K	﹤0.01%	1529
2021 Q4	$272K	Hold	11,915	–	–	﹤0.01%	1800
2021 Q3	$224K	Sell	11,915 -2,408	-17%	-$50.6K	﹤0.01%	1986
2021 Q2	$296K	Buy	14,323 +1,510	+12%	+$29.2K	﹤0.01%	1872
2021 Q1	$214K	Sell	12,813 -1,232	-9%	-$20.8K	﹤0.01%	1977
2020 Q4	$207K	Buy	14,045 +3,859	+38%	+$49K	﹤0.01%	1914
2020 Q3	$104K	Sell	10,186 -4,606	-31%	-$52.2K	﹤0.01%	2194
2020 Q2	$162K	Hold	14,792	–	–	﹤0.01%	1946
2020 Q1	$114K	Buy	14,792 +5,789	+64%	+$49.4K	﹤0.01%	1953
2019 Q4	$89K	Sell	9,003 -7,379	-45%	-$70.3K	﹤0.01%	2394
2019 Q3	$186K	Hold	16,382	–	–	﹤0.01%	1930
2019 Q2	$250K	Hold	16,382	–	–	﹤0.01%	1747
2019 Q1	$224K	Hold	16,382	–	–	﹤0.01%	1828
2018 Q4	$176K	Hold	16,382	–	–	﹤0.01%	1905
2018 Q3	$289K	Hold	16,382	–	–	﹤0.01%	1734
2018 Q2	$243K	Hold	16,382	–	–	﹤0.01%	1814
2018 Q1	$255K	Hold	16,382	–	–	﹤0.01%	1741
2017 Q4	$317K	Sell	16,382 -18,918	-54%	-$420K	﹤0.01%	1585
2017 Q3	$847K	Hold	35,300	–	–	0.01%	1354
2017 Q2	$729K	Hold	35,300	–	–	0.01%	1435
2017 Q1	$732K	Hold	35,300	–	–	0.01%	1403
2016 Q4	$789K	Hold	35,300	–	–	0.01%	1428
2016 Q3	$676K	Hold	35,300	–	–	0.01%	1510
2016 Q2	$658K	Sell	35,300 -1,407	-4%	-$26.8K	﹤0.01%	1526
2016 Q1	$742K	Hold	36,707	–	–	0.01%	1332
2015 Q4	$632K	Hold	36,707	–	–	﹤0.01%	1474
2015 Q3	$536K	Hold	36,707	–	–	﹤0.01%	1590
2015 Q2	$596K	Sell	36,707 -9,550	-21%	-$164K	﹤0.01%	1625
2015 Q1	$864K	Buy	46,257 +4,061	+10%	+$86.4K	0.01%	1286
2014 Q4	$920K	Sell	42,196 -45,220	-52%	-$927K	0.01%	1370
2014 Q3	$1.79M	Sell	87,416 -5,049	-5%	-$113K	0.01%	989
2014 Q2	$2.09M	Sell	92,465 -547	-0.6%	-$12.4K	0.01%	987
2014 Q1	$2.27M	Buy	93,012 +71	+0.1%	+$1.83K	0.02%	921
2013 Q4	$2.51M	Buy	92,941 +73	+0.1%	+$1.84K	0.02%	855
2013 Q3	$2.47M	Sell	92,868 -580	-0.6%	-$15K	0.02%	819
2013 Q2	$2.3M	Buy	+93,448	New	+$2.07M	0.02%	811

Other funds holding ADTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ADTN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Adtran (ADTN) in Q2 2024, closing a stake of 3,056 shares — an estimated $16.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ADTN in Q2 2013 and held it in 44 quarters. The position peaked at $2.51M in Q4 2013. 157 funds tracked by Wall St. Rank hold ADTN as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Adtran position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 3,056 Adtran shares in Q2 2024, an estimated $16.6K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Adtran in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Adtran position peaked at $2.51M in Q4 2013.
157 funds tracked by Wall St. Rank held Adtran as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.